No open-market selling at Plus Therapeutics, Inc. in the past year, which is unusual. Instead one insiders purchased about $10,000 worth of PSTV.
The largest purchase came from Sims Andrew John Hugh MacIntyre (CFO), about $10,000. That includes C-suite money, which tends to get the most attention.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Sims Andrew John Hugh MacIntyre | CFO | Buy | 20,000 | $0.51 | $10K | SEC |
| Aug 25, 2025 | Lenk Robert P | Director | Buy | 110,000 | $0.49 | $54K | SEC |
| Sep 17, 2024 | Hawkins Richard J | Director | Buy | 4,000 | $1.50 | $6K | SEC |
| Sep 16, 2024 | Hawkins Richard J | Director | Buy | 6,285 | $1.35 | $8K | SEC |
| Sep 13, 2024 | Petersen Greg | Director | Buy | 12,500 | $1.35 | $17K | SEC |
| Sep 13, 2024 | Clowes Howard | Director | Buy | 5,000 | $1.34 | $7K | SEC |
| Sep 11, 2024 | HEDRICK MARC H | CEO | Buy | 8,000 | $1.23 | $10K | SEC |
| Sep 11, 2024 | Sims Andrew John Hugh MacIntyre | CFO | Buy | 4,098 | $1.27 | $5K | SEC |
| May 10, 2024 | Sims Andrew John Hugh MacIntyre | CFO | Buy | 4,902 | $2.04 | $10K | SEC |
| May 10, 2024 | HEDRICK MARC H | CEO | Buy | 12,255 | $2.04 | $25K | SEC |
| May 10, 2024 | Petersen Greg | Director | Buy | 12,255 | $2.04 | $25K | SEC |
| May 10, 2024 | Hawkins Richard J | Director | Buy | 4,902 | $2.04 | $10K | SEC |
| May 10, 2024 | Clowes Howard | Director | Buy | 9,804 | $2.04 | $20K | SEC |
| May 10, 2024 | Lenk Robert P | Director | Buy | 4,167 | $2.04 | $9K | SEC |
| Dec 15, 2023 | HEDRICK MARC H | CEO | Sell | 2,068 | $1.96 | $4K | SEC |
In the last 12 months Plus Therapeutics, Inc. insiders made open-market purchases worth about $10,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PSTV was filed on 2025-11-05.
No congressional trades in PSTV were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).